Home » DOJ Official: ‘Everyone Is Doing It’ No Excuse for Off-Label Promotion
DOJ Official: ‘Everyone Is Doing It’ No Excuse for Off-Label Promotion
Last year, the federal government collected $1.45 billion in settlement from pharmaceutical and medical device companies, and the most common charge of alleged misconduct was off-label promotion, according to law firm Skadden.
MedCity News
MedCity News
Upcoming Events
-
07May
-
14May
-
30May